NovaBay® Pharmaceuticals, Inc. ("NovaBay" or the "Company") announces it has entered into a definitive asset purchase agreement (the "Agreement") with PRN Physician Recommended Nutriceuticals, LLC ...
Xdemvy is the first and only approved FDA treatment for Demodex blepharitis Xdemvy can achieve collarette reduction of no more than 2 collarettes in 50% of patients after 6 weeks of treatment.